Figure 4.
Anti-tumor activity of eNK-EXO-DDP in vitro. (A) Schematic diagram showing the preparation of eNK-EXO-DDP. (B) CCK-8 assay showing the cytotoxicity of eNK-EXO-DDP against SKOV3, COC1/DDP and OV-90 cells (n=3, mean ± SEM, **p< 0.01, ***p< 0.001). (C) Flow cytometry analysis of anti-proliferation activity of eNK-EXO-DDP against SKOV3 cells. (D) EdU assay result of anti-proliferation activity of eNK-EXO-DDP against SKOV3 cells, Scale bar=100 µm. (E) Cell cycle analysis of SKOV3 cells after eNK-EXO-DDP treatment by flow cytometry. (F) Apoptosis analysis of SKOV3 cells after eNK-EXO-DDP treatment by flow cytometry. (G) Statistical analysis of apoptosis rate is based on three experiments, mean ± SEM, *p< 0.05, **p< 0.01, ***p< 0.001. (H) Western blot analysis of PARP, cleaved PARP, cleaved caspase 3 and cleaved caspase 7 in SKOV3 and COC1/DDP cells after different treatments.